Samsung Biologics Market Cap

Samsung Biologics has a market cap or net worth of 62.17 trillion as of June 26, 2026. Its market cap has decreased by -16.09% in one year.

Market Cap

62.17T

Enterprise Value

61.71T

Revenue

4.81T

Ranking

n/a

PE Ratio

51.35

Stock Price

1,343,000.00

Market Cap Chart

Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 62.17T, an increase of 552.50%. That is a compound annual growth rate of 21.50%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2026	62.17T	-20.77%
Dec 30, 2025	78.46T	16.17%
Dec 30, 2024	67.54T	24.87%
Dec 28, 2023	54.09T	-7.43%
Dec 29, 2022	58.43T	-2.20%
Dec 30, 2021	59.75T	9.32%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Nov 10, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Celltrion	36.46T
ALTEOGEN	20.09T
Samsung Epis Holdings	10.61T
Kolon TissueGene	8.09T
SK Biopharmaceuticals	6.49T
HLB Co., Ltd.	6.34T
LigaChem Biosciences	5.74T
Peptron	3.89T

Market Cap Rankings